Project description
Smart phone apps are placing rehabilitation of mobility, speech and more in patients' hands
Millions of people live with chronic neurological conditions impairing speech, mobility, cognition and other functions. Regular neurorehabilitation outside the home places a large burden on state healthcare systems. Furthermore, in practice such care is often difficult for a patient to obtain regularly. Reasons include distance of care from a patient’s home, limited access due to high demand and scheduling, and difficulties in traveling due to patient’s impairments. The SME Beats Therapeutics has created smart phone-based apps to help patients at home with neurological assessments, delivery of individually tailored treatment and outcome tracking. EU-funding of the BeatsDigTherapeutics project is helping the company broaden the disease base covered by the apps while enhancing coverage and payment.
Objective
Beats Therapeutics specialises in digital therapeutics for neurological and brain disorders. There are over a billion people worldwide living with a neurological or brain disorder. This has led to pressure on healthcare systems and payers to improve self-management and reduce long-term costs. The high risk and low approval rates of neuro-pharmaceuticals has led to billions of dollars of annual losses for the pharma industry. Many of these failures have been attributed to an insufficient understanding of the brain. We deliver tailored assessments and therapy's for neurological conditions with the aim to improve care and reduce costs while developing a greater understanding of neurological disease. Our core technology platform leverages data science and the advancements in hardware sensors to deliver cost effective daily assessments and individually tailored therapy to patients with neurological conditions. The innovation in this project is to scale up our current core technology platform in order to further deploy the technology in greater disease areas. Project Scale will allow us to enhance our core technology applicability to rapidly deploy disease specific technologies for pharmaceutical industry and payer industry while enhancing our global impact on patients’ lives.
Fields of science
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
D18 F3P9 SANDYFORD DUBLIN
Ireland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.